Oxford Technology 3 VCT PLC

Update for the quarter ending 30 November 2016

Oxford Technology 3 VCT PLC presents its quarterly update for the period commencing 1 September 2016. 

The Directors have recently reviewed the valuation of its entire portfolio as at 30 November 2016.

The unaudited net asset value per ordinary share as at 30 November 2016 was 82.3p. This is a reduction of 5.0p from the previously published NAV for the period ending 31 August 2016 primarily due to a reduction in the valuation of Glide Pharmaceutical Technologies Limited (Glide). Despite making good progress on the technical front, Glide has struggled to raise funds, and is currently contemplating a round at a significant discount to OT3's current NAV. Glide is 9.4% of this latest NAV.

As announced in our RNS on 16^th December 2016 the investment in Allinea has now been sold, yielding an immediate payment of £286k to OT3 with a further £36k to follow.

During the quarter follow on investments were made in Orthogem (£50k) and Arecor (£200k).

The total number of ordinary shares in issue is 6,785,233.

The Directors are not aware of any other events or transactions which have taken place between 1 December 2016 and the publication of this statement which have had a material effect on the financial position of the Company.

11 January 2017

Enquiries:
Lucius Cary, Oxford Technology Management
01865 784466